For all the attention on U.S.-China AI competition, new studies point to China's rapid rise in biotechnology, especially for ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

This week on "The Readout LOUD" podcast: an AI experiment at the FDA and how Novo Nordisk is trailing in the obesity drug ...

In this episode of Denatured, presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses how AI transformation can ...

Researchers from Peking Union Medical College Hospital and artificial intelligence (AI) drug developer Insilico Medicine ...

Clinical trials, traditionally plagued by low success rates and high operational costs, are being reengineered through AI ...

Researchers report that rentosertib, an AI-discovered TNIK inhibitor, showed promising safety and potential to improve lung ...

FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't ...

VANCOUVER, BC / ACCESS Newswire / June 5, 2025 / Onco-Innovations Limited (CBOE:ONCO)(Frankfurt:W1H,WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its wholly-owned subsidiary, Inka ...

EVP, Chief Medical Officer and Chief Product Officer, SOPHiA GENETICS | Embrace the transformative power of multimodal AI-driven analytics to accelerate innovation and realize the full potential of ...

An investment management firm known for short-selling the stocks it speaks against is now targeting a high-risk, high-reward ...